Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial
Purpose/Objective(s): To analyze the long term efficacy and safety of an ultra-hypofractionated (UHF) radiation therapy prostate treatment regimen with HDR brachytherapy boost (BB) and compare it to moderate-hypofractionated regimens (MHF). Materials/Methods: In this single arm, prospective monocent...
Main Authors: | M.M. Beaudry, D. Carignan, W. Foster, M.C. Lavallee, S. Aubin, F. Lacroix, E. Poulin, B. Lachance, P. Després, L. Beaulieu, E. Vigneault, A.G. Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | Clinical and Translational Radiation Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405630823000186 |
Similar Items
-
Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives
by: Maria Chiara Lo Greco, et al.
Published: (2023-06-01) -
RECURRENT SKIN CANCER AFTER BRACHYTHERAPY IN THE MODE OF DOSE HYPOFRACTIONATION AND SINGLE IRRADIATION
by: Zhmakina E. D., et al.
Published: (2019-05-01) -
DIRECT AND NEAREST RESULTS OF BRACHYTHERAPY IN DOSE HYPOFRACTIONATION MODE AND SINGLE IRRADIATION IN STAGE I-II SKIN CANCER
by: Zhmakina E. D., et al.
Published: (2018-09-01) -
Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost
by: Christina Phuong, et al.
Published: (2022-01-01) -
Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial
by: Lucas C. Mendez, et al.
Published: (2020-10-01)